Athira Pharma, Inc. (ATHA)

Last Year

20-May-23 -- 19-May-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

8

0

6

+1

0

+2

0

+3

Two Year Chart

20-May-22 -- 19-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
08-Jan-24 4:45 PM View:	04-Jan-24 Grant 0	Moebius Hans Chief Medical Officer		Athira Pharma, Inc. - ATHA	24% 73.6K to 91.48K	0	0	--	--	Show Txns Hide Txns

08-Jan-24 4:38 PM View:	05-Jan-24 Sale ($7.02K)	Worthington Mark General Counsel		Athira Pharma, Inc. - ATHA	28% 26.86K to 34.45K	0	0	--	--	Show Txns Hide Txns

29-Dec-23 5:24 PM View:	29-Dec-23 Purchase $390.21K	Perceptive Advisors LLC Director 10% Owner		Athira Pharma, Inc. - ATHA	13% 4.8M to 5.4M	0	0	--	--	Show Txns Hide Txns

08-Jan-24 4:36 PM View:	20-Nov-23 Grant $4.55K	Church Kevin Chief Scientific Officer		Athira Pharma, Inc. - ATHA	5% 69.27K to 72.67K	0	0	--	--	Show Txns Hide Txns

09-Jun-23 5:06 PM View:	07-Jun-23 Private Purchase $51.44K	Gengos Andrew CFO AND CHIEF BUSINESS OFFICER		Athira Pharma, Inc. - ATHA	100% 0 to 80.01K	0	0	--	--	Show Txns Hide Txns

08-Jan-24 4:40 PM View:	05-Jan-24 Sale ($14.03K)	Litton Mark James CEO Director		Athira Pharma, Inc. - ATHA	10% 148.91K to 164.09K	0	0	--	--	Show Txns Hide Txns

08-Jan-24 4:35 PM View:	05-Jan-24 Sale ($7.02K)	Lenington Rachel COO AND CDO		Athira Pharma, Inc. - ATHA	131% 5.81K to 13.39K	0	0	--	--	Show Txns Hide Txns